Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

AIFA, the Italian Medicines Agency and the agency tasked with both pricing and reimbursement of medicines in Italy, published a consultation on their guidance on criteria and methods for pricing ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Prior to the EMA role, Rasi was director-general of the Italian Medicines Agency from 2008, and previously spent three years as director of the Institute of Molecular Medicine in Rome.

Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogsJaguar is exploring the possib ...

Psychedelics devotees are racing biotech entrepreneurs to turn 5-MeO-DMT, one of the world’s most powerful drugs, into a ...

Addis Ababa, June 5, 2025 (ENA) -- The African Union (AU) announced the appointment of the first Director-General for the African Medicines Agency (AMA). The AMA Treaty was adopted by the AU ...

General News of Wednesday, 4 June 2025. Source: www.ghanaweb.com 2025-06-04 Ghana's FDA boss appointed Head of African Medicines Agency of the African Union ...